sodium bisulfide has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorofeyeva, N; Drachuk, K; Rajkumar, R; Sabnis, O; Sagach, V | 1 |
| Imai, E; Kimura, T; Kojima, H; Kosugi, T; Maruyama, S; Matsuo, S; Niki, I; Sato, W; Taniguchi, S; Yamamoto, J; Yamamoto, T; Yuzawa, Y | 1 |
2 other study(ies) available for sodium bisulfide and Diabetes Mellitus
| Article | Year |
|---|---|
H
Topics: Acetylcholine; Animals; Aorta, Thoracic; Cardiac Output; Diabetes Mellitus; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Heart; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Stroke Volume; Sulfides; Vasodilation; Vasodilator Agents | 2021 |
Distribution of hydrogen sulfide (H₂S)-producing enzymes and the roles of the H₂S donor sodium hydrosulfide in diabetic nephropathy.
Topics: Animals; Calmodulin; Capillaries; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Hydrogen Sulfide; Kidney; Mice; Mice, Inbred ICR; Mice, Transgenic; Microcirculation; Regional Blood Flow; Renal Circulation; Sulfides; Vasoconstriction | 2013 |